Sean David to Polymorphism, Single Nucleotide
This is a "connection" page, showing publications Sean David has written about Polymorphism, Single Nucleotide.
Connection Strength
1.227
-
Model-based assessment of replicability for genome-wide association meta-analysis. Nat Commun. 2021 03 30; 12(1):1964.
Score: 0.205
-
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85.
Score: 0.169
-
Rare genetic variants explain missing heritability in smoking. Nat Hum Behav. 2022 11; 6(11):1577-1586.
Score: 0.112
-
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat Commun. 2018 07 04; 9(1):2606.
Score: 0.085
-
Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016 Feb; 4:153-61.
Score: 0.071
-
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Clin Pharmacol Ther. 2014 Aug; 96(2):256-65.
Score: 0.063
-
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause. 2014 Apr; 21(4):415-20.
Score: 0.063
-
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry. 2012 May 22; 2:e119.
Score: 0.055
-
Genome sequencing unveils a regulatory landscape of platelet reactivity. Nat Commun. 2021 Jun 15; 12(1):3626.
Score: 0.052
-
Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. Nicotine Tob Res. 2010 Mar; 12(3):251-62.
Score: 0.047
-
Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res. 2009 Jan; 11(1):64-76.
Score: 0.044
-
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun; 65(6):683-93.
Score: 0.042
-
Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing. Nat Genet. 2023 Feb; 55(2):291-300.
Score: 0.029
-
Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data. Nat Genet. 2022 Mar; 54(3):263-273.
Score: 0.027
-
Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices. Nat Commun. 2021 04 12; 12(1):2182.
Score: 0.026
-
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021 Feb; 590(7845):290-299.
Score: 0.025
-
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence? Nicotine Tob Res. 2019 08 19; 21(9):1289-1293.
Score: 0.023
-
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. Mol Psychiatry. 2020 10; 25(10):2392-2409.
Score: 0.022
-
Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use. Biol Psychiatry. 2019 06 01; 85(11):946-955.
Score: 0.022
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 09 08; 9:CD011823.
Score: 0.020
-
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):7-13.
Score: 0.013
-
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010 Mar; 11(3):357-67.
Score: 0.012